Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,019 | -45,189 | -30,108 | -39,081 | -56,948 |
| Depreciation Amortization | 1,189 | 766 | 743 | 1,067 | 1,242 |
| Accounts receivable | 3,247 | -7,375 | 2,447 | 1,269 | 24,396 |
| Accounts payable and accrued liabilities | N/A | N/A | -2,049 | N/A | N/A |
| Other Working Capital | 18,445 | 1,155 | 3,808 | -4,299 | 14,683 |
| Other Operating Activity | 7,022 | 12,092 | -1,371 | 3,647 | -15,624 |
| Operating Cash Flow | $-13,116 | $-38,551 | $-26,530 | $-37,397 | $-32,251 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,420 | -39,875 | -3,644 | 24,680 | 11,373 |
| PPE Investments | -5,122 | -106 | 20 | -113 | -55 |
| Other Investing Activity | -1,462 | 1 | 157 | 317 | 0 |
| Investing Cash Flow | $-18,004 | $-39,980 | $-3,467 | $24,884 | $11,318 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 25,691 |
| Common Stock Issued | 5,479 | 111,907 | 25,090 | 18,660 | 1,605 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -61 |
| Other Financing Activity | 0 | 0 | 5,180 | -1,700 | -3,480 |
| Financing Cash Flow | $5,479 | $111,907 | $30,270 | $16,960 | $23,755 |
| Beginning Cash Position | 54,540 | 21,164 | 20,891 | 16,444 | 13,622 |
| End Cash Position | 28,899 | 54,540 | 21,164 | 20,891 | 16,444 |
| Net Cash Flow | $-25,641 | $33,376 | $273 | $4,447 | $2,822 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,116 | -38,551 | -26,530 | -37,397 | -32,251 |
| Capital Expenditure | -5,122 | -106 | -30 | -113 | -55 |
| Free Cash Flow | -18,238 | -38,657 | -26,560 | -37,510 | -32,306 |